NCT05162911

Brief Summary

The primary objective of this study is to conduct a 3-arm randomized controlled trial (RCT) that compares the effectiveness of three multi-component interventions that are embedded in HIV outpatient clinics (OPCs): 1)3As+Referral to the national quitline: Ask about tobacco use, Advise to quit, Assist with brief counseling and Refer to Viet Nam's national Quitline; 2) AAA+ +Counsel (Counsel=6-session cessation counseling intervention adapted for patients living with HIV/AIDS (PLWH) and delivered by a trained, onsite nurse; and 3) AAA+Counsel+N (N=nicotine replacement therapy (NRT)). The main outcome is biochemically validated 6-months smoking abstinence. The investigators will recruit and randomize 672 patients across 13 outpatient clinics (OPCs) (48 per site, 16 per arm). The investigators will also recruit 75-nonsmokers to participate in a single survey to assess food safety. Therefore, the total sample = 747 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
672

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

November 23, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 17, 2021

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

4.4 years

First QC Date

November 10, 2021

Last Update Submit

May 28, 2026

Conditions

Keywords

Tobacco UseImplementation Science

Outcome Measures

Primary Outcomes (1)

  • Carbon test at 6-months of smoking abstinence

    biochemically validated 6-months smoking abstinence will be measured using expired-air carbon monoxide reading equal to or less than 8 ppm (CO \< 8 ppm). The scale is 0-50ppm, where the lowest values represent less CO levels, which indicate a patient is not smoking, and the highest values represent higher CO levels indicating a patient is actively smoking.

    6-months smoking abstinence

Secondary Outcomes (1)

  • Factors that may influence tobacco cessation, and sustainability of the interventions tested

    18 months

Study Arms (3)

Ask, Advise, Assist (AAA) and Refer.

ACTIVE COMPARATOR

Patients will receive Ask, Advise, Assist (AAA) and refer to the quitline as the intervention.

Behavioral: Ask, advise, Assist and refer to the Quitline

AAA plus referral to onsite counselor (Counsel).

ACTIVE COMPARATOR

Patients will receive Ask, Advise, Assist plus referral to onsite counselor.

Behavioral: Ask, advise, Assist and referral to onsite counselor

AAA+Counsel+N (Nicotine gum).

ACTIVE COMPARATOR

Patients will receive Ask, Advise, Assist, plus referral to onsite counselor and nicotine gum.

Behavioral: Ask, advise, Assist and referral to onsite counselor and NRT

Interventions

A nurse will ask, advise, assist and refer patient to the Quitline

Ask, Advise, Assist (AAA) and Refer.

A nurse will ask, advise, assist and refer patient to a counselor

AAA plus referral to onsite counselor (Counsel).

A nurse will ask, advise, assist and refer patient to a counselor and provide nicotine replacement therapy in the form of gum

AAA+Counsel+N (Nicotine gum).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients in the HIV OPCs
  • current tobacco users
  • patients who live in Hanoi
  • patients reachable by phone

You may not qualify if:

  • patients for whom there is a need for precaution in using NRT will be excluded
  • patients with recent myocardial infarction (2 weeks)
  • patients serious underlying arrhythmias
  • patients who are pregnant or nursing
  • patients are unable to demonstrate capacity for consent
  • patients already enrolled in a tobacco use treatment program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nam Nguyen

Hanoi, Nam Tu Liem, 2QJG+94, Vietnam

Location

Related Publications (2)

  • Shelley D, Armstrong-Hough M, Nguyen T, Alvarez GG, Kapur R, Shuter J, Goldsamt L, Tozan Y, Van Minh H, Van Vu G, Phan PT, Cleland CM, Nguyen N. Effectiveness of behavioural tobacco cessation interventions with and without pharmacotherapy among people living with HIV in Viet Nam: a three-arm pragmatic randomised controlled trial. Lancet Glob Health. 2026 Mar;14(3):e407-e416. doi: 10.1016/S2214-109X(25)00451-6.

  • Shelley D, Alvarez GG, Nguyen T, Nguyen N, Goldsamt L, Cleland C, Tozan Y, Shuter J, Armstrong-Hough M. Adapting a tobacco cessation treatment intervention and implementation strategies to enhance implementation effectiveness and clinical outcomes in the context of HIV care in Vietnam: a case study. Implement Sci Commun. 2022 Oct 17;3(1):112. doi: 10.1186/s43058-022-00361-8.

MeSH Terms

Conditions

Tobacco Use

Interventions

corticosteroid hormone-induced factorInsemination, Artificial, HeterologousNicotine Replacement Therapy

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Insemination, ArtificialReproductive Techniques, AssistedReproductive TechniquesTherapeuticsInvestigative TechniquesInseminationReproductionReproductive Physiological PhenomenaReproductive and Urinary Physiological PhenomenaDrug Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: randomized control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2021

First Posted

December 17, 2021

Study Start

November 23, 2021

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

June 1, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations